share_log

宜明昂科境内未上市股份“全流通”获中国证监会备案

The unlisted domestic shares of Yiming Anke have been fully converted and approved by the China Securities Regulatory Commission.

Breakings ·  09:19

The International Cooperation Department of the China Securities Regulatory Commission issued a notification on the registration of the fully circulating unlisted domestic shares of Yiming Anke Biomedical Technology (Shanghai) Co., Ltd. Seven shareholders of the company intend to convert a total of 14,114,006 shares of unlisted domestic shares into overseas listed shares and list them for circulation on the Hong Kong Stock Exchange.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 349

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.